Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parietal position canalith repositioning vs medication for posterior canal short-arm BPPV
jRCT1071230105Recruiting
- Sponsor
- K Pharma
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of betahistine in benign paroxysmal positional vertigo (BPPV) (2 arms), sponsored by K Pharma. Primary endpoint: Disappearance of positional nystagmus. Started Jan 2024; status: recruiting.
02
Drugs
betahistine
03
Conditions
benign paroxysmal positional vertigo (BPPV)
Beyond the preview
Go deeper on jRCT1071230105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1071230105.